We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization's three priority diseases - HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. Our product portfolio also includes a range of consumer brands, many of which are household names around the world, including Sensodyne, Aquafresh, Horlicks, Panadol and Tums.
GlaxoSmithKline
Venture CapitalWe are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare.
18
Total Investments
14
Portfolio Companies
-
Exits
2
Industries
General Information
Company Overview
Investment Criteria
•••••• •••••• ••••••
About GlaxoSmithKline
Recent Investments (18)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Jul 2024 | |
| Series C | •••••• | May 2024 | |
| Grant | •••••• | May 2023 | |
| Seed Round | •••••• | Apr 2023 | |
| Series C | •••••• | Mar 2022 | |
|
|
Venture Round | •••••• | Sep 2019 |
|
|
Series B | •••••• | Apr 2019 |
|
|
Series A | •••••• | Nov 2015 |
|
|
Series C | •••••• | Aug 2013 |
|
|
Post-IPO Equity | •••••• | Jul 2012 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.